Skip to main content
AB

Akoya Biosciences

Akoya Biosciences provides high-parameter tissue analysis solutions through its PhenoCode™ Discovery IO60 panel, which enables ultrahigh-plex spatial phenotyping of up to 60 biomarkers in a single sample. This technology facilitates the discovery and validation of biomarkers, enhancing drug development and precision medicine by delivering actionable insights from complex tissue samples.

Marlborough, United StatesFounded 201523930K+ followers
Updated 4 months ago

Funding

$43.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Traditional methods of tissue analysis often lack the ability to simultaneously analyze a large number of biomarkers within a single tissue sample, hindering comprehensive understanding of complex biological processes. This limitation slows down the discovery and validation of biomarkers, which are crucial for advancing drug development and precision medicine.

Solution

Akoya Biosciences addresses this by providing high-parameter tissue analysis solutions, exemplified by their PhenoCode™ Discovery IO60 panel, enabling ultrahigh-plex spatial phenotyping of up to 60 biomarkers in a single sample. This technology facilitates the discovery and validation of biomarkers by delivering actionable insights from complex tissue samples. The PhenoCode™ panels streamline spatial biology workflows, accelerating the translation of discoveries into actionable spatial signatures. Akoya's solutions empower researchers to conduct spatial studies at scale, generating human-scale spatial atlases and unlocking a deeper understanding of human biology and disease.

Target Audience

The primary audience includes researchers and biopharma companies involved in biomarker discovery, drug development, and precision medicine, seeking comprehensive, high-throughput tissue analysis solutions.

Features

  • Ultrahigh-plex spatial phenotyping of up to 60 biomarkers in a single tissue sample
  • Compatibility with PhenoCycler®-Fusion and PhenoImager® HT platforms
  • Streamlined workflow for rapid and impactful discoveries
  • Enables the development of actionable spatial signatures
  • Facilitates spatial studies from single samples to large-scale, population-level analyses
  • High-speed whole-slide imaging powered by patented height-sensing optics
  • Scalable multiplexing enabled by patented barcoded antibody technology
  • Proprietary high-resolution QPTIFF files for manageable data size
This profile is AI-generated and may contain inaccuracies.